Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Event Oct 24 - Oct 26, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress Theme: The future of next generation Biosimilars and Biologics Home | Conference Brochure | Submit Abstract Frontiers Meetings takes pleasure in inviting the scientific community across the globe to attend the Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress during October 24-26, 2019 at Rome, Italy with a motto to Explore Innovations in Biosimilars & Biologics. This Biosimilars 2019 Conference will bring together Professors, scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials, CROs and students from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and Biosimilars.
Biosimilars 2019 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. Rewards for the Best Oral and Poster Presentation is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase. The important tracks that are part of Biosimilars 2019 includes: Challenges in Biosimilars and Biologics Development, Biosimilars Analytical Strategies, Formulation Strategies for Follow-on Biologics, BPCIA and Regulatory Updates, Intellectual Property Rights for Biosimilars, Biologics as therapeutics, Emerging Biosimilars and research pipelines, Monoclonal Antibody Biosimilars, BCS and IVIVC Based Biowaivers, Biogenerics and Biopharmaceuticals, Biosimilars Clinical Research and Pharmacovigilance, Clinicians Approach for Biosimilars, Globalization of Biosimilars, Biosimilars Market and Cost Analysis, Globalization of Biosimilars and Brexit Conundrums on Biosimilars Biosimilars 2019 is comprised of 16 tracks and 90 sessions designed to offer comprehensive sessions that address current issue.